Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

Heart, Artery and Coronary DiseasesHeart Failure

Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study

J Am Heart Assoc

Martinez-Morata I, Domingo-Relloso A, Zhang Y, Fretts AM, Pichler G, Garcia Pinilla JM, Umans JG, Cole SA, Sun Y, Shimbo D, Navas-Acien A, Devereux RB

doi: 10.1161/JAHA.123.033772

Heart Failure

Heart failure in patients with congenital heart disease after a cancer diagnosis

ESC Heart Fail

Karazisi C, Dellborg M, Mellgren K, Giang KW, Skoglund K, Eriksson P, Mandalenakis Z

doi: 10.1002/ehf2.14945

Heart Failure

Long-term rate of heart failure in patients with autoimmune disease: A nationwide cohort study

Eur J Heart Fail

Sun G, Fosbøl EL, Faurschou M, Schou M, Torp-Pedersen C, Køber L, Butt JH

doi: 10.1002/ejhf.3541

Cardiovascular Risk and Diseases

Population-level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial

Diabetes Obes Metab

Nanna MG, Doan QV, Fabricatore A, Faurby M, Henry AD, Houshmand-Oeregaard AS, Levine A, Navar AM, Scassellati Sforzolini T, Toliver JC

doi: 10.1111/dom.16370

Heart Failure

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study

Eur J Heart Fail

Leong DP, Joseph PG, Dokainish H, Störk S, McMurray JVV, Mielniczuk LM, Sharma SK, Orlandini A, Karaye KM, Bayes-Genis A, McCready T, Grinvalds A, Balasubramanian K, Branch KR, Kragholm K, Yusuf S, on behalf of the G‐CHF Investigators

doi: 10.1002/ejhf.3550

Heart Failure

A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic

Eur J Heart Fail

Cannata A, Mizani MA, Bromage DI, Piper SE, Hardman SMC, Sudlow C, de Belder M, Deanfield J, Gardner RS, Clark AL, Cleland JGF, McDonagh TA, on behalf of the CVD‐COVID‐UK/COVID‐IMPACT Consortium

doi: 10.1002/ejhf.3306

Heart Failure

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

ESC Heart Fail

Kocabas U, Ergin I, Yavuz V, Altın C, Kaplan M, Yılmaz Öztekin GM, Doğduş M, Murat S, Murat B, Kıvrak T, Karabulut D, Kaya E, Özdemir İH, Yıldız C, Salkın FÖ, Özçalık E, Polatkan ŞG, Çakan F, Şen T, Karabulut U, Çakal S, Oflar E, Sinan ÜY, Yenerçağ M, Türk UÖ

doi: 10.1002/ehf2.15049

Heart Failure

Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort study

Eur J Heart Fail

Zahir Anjum D, Strange JE, Fosbøl E, Garred CH, Elmegaard M, Andersson C, Jhund PS, McMurray JJV, Petrie MC, Kober L, Schou M

doi: 10.1002/ejhf.3249

Heart Failure

Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk Score

J Am Heart Assoc

Abassi NK, Nouhravesh N, Elmegaard M, Austreim M, Zahir D, Garred CH, Butt JH, Andersen CF, Strange JE, Sindet-Pedersen C, Christensen DM, Fosbøl E, Andersson C, Køber L, Schou M

doi: 10.1161/JAHA.124.037973

Related content

Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study

Heart failure in patients with congenital heart disease after a cancer diagnosis

Long-term rate of heart failure in patients with autoimmune disease: A nationwide cohort study

Population-level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial

The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study

A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic

Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART study

Use of medical therapy and risk of clinical events according to frailty in heart failure patients - A real-life cohort study

Temporal Trends in Mortality and Hospitalization Risk in Patients With Heart Failure According to the Hospital Frailty Risk Score